FDA.reportPublic FDA data

Senna-S

Manufacturer
NUVICARE LLC
Effective date
2025-12-19
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 01:27:19

Label at a glance#

ProductSenna-S
Active ingredientDOCUSATE SODIUM, SENNOSIDES
Label structure13 sections

Indications and uses

Relieves occasional constipation (irregularity). Generally produces a bowel movement in 6 to 12 hours.

Dosage and administration

Take preferably at bedtime or as directed by a doctor. age starting dosage maximum dosage adults & children 12 years of age and over 2 tablets once a day 4 tablets twice a day children 6 to under 12 years 1 tablet once a day 2 tablets twice a day children 2 to under 6 years 1 /2 tablet once a day 1 tablet twice a day children under 2 years ask a doctor ask a doctor

Label contents#

Full prescribing information#

Active Ingredients (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Docusate Sodium 50 mg

Sennosides 8.6 mg

Purpose

OTC - PURPOSE SECTION

Docusate Sodium............... Stool softener

Sennosides........................Laxative

Uses:

INDICATIONS & USAGE SECTION

  • Relieves occasional constipation (irregularity).
  • Generally produces a bowel movement in 6 to 12 hours.

Warnings:

WARNINGS SECTION

Do not use: If you are now taking mineral oil, unless directed by a doctor. Laxative products for longer than 1 week, unless directed by a doctor.

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have: 

  • Stomach pain
  • nausea
  • vomiting
  • Noticed a sudden change in bowel habits that continues over a period of 2 weeks.

OTC - STOP USE SECTION

Stop use and ask a doctor if you have:

  • Rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

OTC - PREGNANCY OR BREAST FEEDING SECTION

  • If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

Take preferably at bedtime or as directed by a doctor.

age

starting dosage

maximum dosage

adults & children 12 years of age and over

2 tablets once a day

4 tablets twice a day

children 6 to under 12 years

1 tablet once a day

2 tablets twice a day

children 2 to under 6 years

1 /2 tablet once a day

1 tablet twice a day

children under 2 years

ask a doctor

ask a doctor

OTHER INFORMATION

OTHER SAFETY INFORMATION

  • Each tablet contains: Calcium 19.92 mg, Sodium 5.61 mg VERY LOW SODIUM
  • store at 25°C (77°F) excursions permitted between15°-30°C (59°-86°F)

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Croscarmellose Sodium, Colloidal Silicon Dioxide, Dicalcium Phosphate, F D & C Red, Hypromellose, Magnesium Stearate, Microcrystalline Cellulose, Maltodextrin, Polyethylene Glycol, Stearic acid Powder, Titanium Dioxide.

QUESTIONS OR COMMENTS?

OTC - QUESTIONS SECTION

Call 1 (718) 337-8733 or visit: support@nuvicare.com

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PL0212-00 NC-Senna-S-Senokot-100ctPL0212-00 NC-Senna-S-Senokot-100ct

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
998740sennosides 8.6 MG / docusate sodium 50 MG Oral TabletPSN2
998740docusate sodium 50 MG / sennosides, USP 8.6 MG Oral TabletSCD2
998740DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral TabletSY2

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130384324000114GTIN-13: 0384324000114
EAN-13: 0384324000114
GTIN-12: 384324000114
UPC-A: 384324000114
GTIN storage (14 digits): 00384324000114		PL0212-00 NC-Senna-S-Senokot-100ct.jpg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84324-013-01Senna-S100 in 1 BOTTLETABLET1002

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84324-01384324-013-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 13 matching rows.

Name, UNII, Kind table
NameUNIIKind
DOCUSATE SODIUMF05Q2T2JA0ACTIB
SENNOSIDES3FYP5M0IJXACTIB
Croscarmellose SodiumM28OL1HH48IACT
Silicon DioxideETJ7Z6XBU4IACT
ANHYDROUS DIBASIC CALCIUM PHOSPHATEL11K75P92JIACT
FD&C RED NO. 3PN2ZH5LOQYIACT
HYPROMELLOSE, UNSPECIFIED3NXW29V3WOIACT
Magnesium Stearate70097M6I30IACT
Microcrystalline CelluloseOP1R32D61UIACT
Maltodextrin7CVR7L4A2DIACT
POLYETHYLENE GLYCOL, UNSPECIFIED3WJQ0SDW1AIACT
STEARIC ACID4ELV7Z65APIACT
Titanium Dioxide15FIX9V2JPIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Senna-SSENNOSIDES 8.6 MG AND DOCUSATE SODIUM 50 MGNUVICARE LLC9e999e4a-2f72-4a2b-a41b-bdd68bf5a3502025-12-19WarningsExact identifier
ndc (package): 84324-013-01
ndc (product): 84324-013
ndc11 (package): 84324001301
spl id: 948d9245-227b-4de5-ac6d-6d28af9e2339
spl set id: 9e999e4a-2f72-4a2b-a41b-bdd68bf5a350

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.